Log in

Relevant bibliographies by topics / Zambia Adult Education Advisory Board

Contents

Journal articles

Academic literature on the topic 'Zambia Adult Education Advisory Board'

Author: Grafiati

Published: 28 July 2024

Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Zambia Adult Education Advisory Board.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Zambia Adult Education Advisory Board"

1

Ibidunni, Laura, Kristin Paulyson Nunez, Jude C. Jonassaint, and Laura De Castro. "Regional Differences in the Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health and Family Planning: A Sub-Analysis." Blood 134, Supplement_1 (2019): 2114. http://dx.doi.org/10.1182/blood-2019-129554.

Full text

Abstract:

Background. Sickle cell disease (SCD) remains the most common genetic hematologic disorder, with a disproportionally high incidence and prevalence in African countries. It is associated with an increased risk of maternal and infant morbidity and mortality compared to the general population. As more young adults living with SCD reach healthier reproductive ages, it is imperative that there is open communication between providers and patients regarding reproductive health, maternal risks associated with childbirth, and the risk of having children who inherit SCD. It is also important that provid

APA, Harvard, Vancouver, ISO, and other styles

2

Habibi, Anoosha, Stephanie Ngo, Etienne Audureau, et al. "Causes of Death in 198 Sickle Cell Adult Patients: Old and New Trends." Blood 134, Supplement_1 (2019): 1031. http://dx.doi.org/10.1182/blood-2019-131304.

Full text

Abstract:

Introduction: Over the past decades, there have been substantial improvements in the medical care of sickle cell patients, leading to an increase in life expectancy, despite the fact that the latest studies in adults do not see any change in age at death. Pediatric mortality has declined significantly with the introduction of systematic antibiotics, the preventive care cerebral vasculopathy and therapeutic education for families. It seems important to analyze the morbidity and mortality risks to decide the necessary preventive measures. In this study we will describe the circumstances of death

APA, Harvard, Vancouver, ISO, and other styles

3

Liu, Zhi-Jian, Emoke Deschmann, Haley E. Ramsey, et al. "Dose-Dependent Iron Chelating Effects of Eltrombopag on in Vitro Human Megakaryopoiesis." Blood 134, Supplement_1 (2019): 2475. http://dx.doi.org/10.1182/blood-2019-131895.

Full text

Abstract:

Eltrombopag (ELT), a small molecular thrombopoietin (TPO) mimetic approved for children and adults, could offer a therapeutic alternative to selected neonates and young children with chronic thrombocytopenias. ELT has also been proposed as a potential anti-cancer drug due to its anti-proliferative effects in tumor cells, which are mediated by its strong iron chelating properties. This raises the potential concern that rapidly proliferating normal cells, like bone marrow cells in neonates or young infants, could also be susceptible to the anti-proliferative effects of ELT. In this study, we fir

APA, Harvard, Vancouver, ISO, and other styles

4

Duncan, Alexander, Angela Kellum, Shilpa Jain, et al. "Disease Burden in Patients with Glanzmann Thrombasthenia: Perspectives from the Glanzmann Thrombasthenia Patient/Caregiver Questionnaire." Blood 134, Supplement_1 (2019): 3456. http://dx.doi.org/10.1182/blood-2019-128408.

Full text

Abstract:

Introduction: Glanzmann thrombasthenia (GT) is a rare bleeding disorder (~1:1,000,000) caused by impaired function of platelet glycoprotein IIb/IIIa responsible for aggregation. This novel survey was designed to identify the burden of GT through better understanding of the management of the disorder and its psychosocial impact on patients and caregivers. Methods: Participants were recruited via a rare disease specialty recruiter from Comprehensive Health Education Services. Data were collected from January 31 through March 12, 2019, via a moderator-assisted online survey. On average, the surve

APA, Harvard, Vancouver, ISO, and other styles

5

Panayiotidis, Panayiotis, Gayane Tumyan, Catherine Thieblemont, et al. "Primary Analysis of the Tegar Study: A Phase II Study Exploring the Safety and Efficacy of Atezolizumab in Combination with Obinutuzumab or Rituximab in Patients with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), or Waldenstrom Macroglobulinemia (WM)." Blood 136, Supplement 1 (2020): 2–3. http://dx.doi.org/10.1182/blood-2020-137087.

Full text

Abstract:

Introduction:Treatment options for R/R MCL, MZL and WM are limited. New combinations are in development. A previous Phase Ib study evaluating atezolizumab (A) in combination with obinutuzumab (O) in patients (pts) with R/R NHL reported no new safety signals and overall response rates of 57% and 16% in follicular lymphoma and diffuse large B-cell lymphoma pts, respectively (Palomba, et al. ICML 2017). The Phase II TEGAR study (EudraCT: 2016-003579-22) evaluated the safety and efficacy of A in combination with O or rituximab (R) in pts with R/R MCL, MZL or WM. Methods:R/R MCL or WM pts received

APA, Harvard, Vancouver, ISO, and other styles

6

Sriskandarajah, Priya, Clare Oni, Claire Woodley, et al. "'Application of Prognostic Scoring in Systemic Mastocytosis Patients within a UK Centre of Excellence: Guys and St Thomas' NHS Foundation Trust.'." Blood 138, Supplement 1 (2021): 3625. http://dx.doi.org/10.1182/blood-2021-152234.

Full text

Abstract:

Abstract Background: Systemic mastocytosis (SM) is a disorder of neoplastic mast cells ranging from indolent to aggressive multi-system disease. We previously reported our large single centre experience managing SM. Since 2019 patients have had access to new treatments within trials. Prognostic scoring systems developed in SM to improve outcome predictions and guide treatment have been a focus of recent studies, although are yet to be validated in real-world setting. We sought to apply these scoring systems within our UK cohort, with a particular focus on the international prognostic score (IP

APA, Harvard, Vancouver, ISO, and other styles

7

Geissler, Jan, Fabio Efficace, Felice Bombaci, et al. "Factors Predicting Intentional Non-Adherence In Chronic Myeloid Leukemia: A Multivariate Analysis On 2546 Patients By The CML Advocates Network." Blood 122, no. 21 (2013): 4023. http://dx.doi.org/10.1182/blood.v122.21.4023.4023.

Full text

Abstract:

Abstract Background Adherence to the prescribed dose of tyrosine kinase inhibitors (TKIs) is critical to maximize treatment effectiveness in chronic myeloid leukemia (CML). While patient-centered outcome studies are lacking in this area, literature has shown that a significant proportion of patients report both intentional and unintentional non-adherence. Objective The main objective of this multivariate analysis was to identify risk factors that might predict intentional non-adherence to TKIs in CML. Methods The CML Advocates Network, connecting 79 CML patient groups from 63 countries, conduc

APA, Harvard, Vancouver, ISO, and other styles

8

El-Jawahri, Areej, Christa Meyer, Lih-Wen Mau, et al. "What Do Patients Think about Palliative Care? a National Survey of Hematopoietic Stem Cell Transplant Recipients." Blood 138, Supplement 1 (2021): 2968. http://dx.doi.org/10.1182/blood-2021-149766.

Full text

Abstract:

Abstract Background: Palliative care (PC) benefits patients with cancer and those undergoing hematopoietic stem cell transplantation (HSCT), but remains under-utilized in HSCT. While transplant physicians have substantial concerns regarding how patients perceive PC, studies examining HSCT recipients' perceptions of PC are lacking. Methods: Between 11/2020-4/2021, the CIBMTR Survey Research Group conducted a multi-site cross-sectional survey of adult autologous and allogeneic HSCT recipients at 11 transplant centers in the United States who were 3-12 months post-transplant to assess their exper

APA, Harvard, Vancouver, ISO, and other styles

9

Marchesi, Francesco, Jon Salmanton-García, Alberto Lopez-Garcia, et al. "COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)." Blood 138, Supplement 1 (2021): 3733. http://dx.doi.org/10.1182/blood-2021-147295.

Full text

Abstract:

Abstract Introduction Coronavirus disease 2019 (COVID-19) is a life-threatening condition of high relevance for co-morbid patients, such as those with baseline hematological malignancies (HM). One year after the diagnosis of the first COVID-19 case, at the end of 2020, the first vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were administered to the population, starting with individuals at highest risk of infection. EPICOVIDEHA aims to describe the epidemiology, vaccination strategies and mortality rates from HM patients at risk. Methods We collected clinical

APA, Harvard, Vancouver, ISO, and other styles

10

Nguyen, An Thi, Sharon Burnside, Kristin Junge, Emily Kling Somerville, Marian Keglovits, and Susan Lynn Stark. "Synergizing geriatric research and education in an allied health profession with an older adult community advisory board: development and process outcomes." Educational Gerontology 46, no. 8 (2020): 486–96. http://dx.doi.org/10.1080/03601277.2020.1780369.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!